THE ROLE OF MALATYADI TAILA AND ANKOLADI TAILA IN THE MANAGEMENT OF ARUMSHI/RUNSHI.

Phase 2

• Conditions: Health Condition 1: L210- Seborrhea capitis

• Registration Number: CTRI/2021/05/033413
• Lead Sponsor: AGESHWAR PHARMACY

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 17 October 2022

Recruitment & Eligibility

• Status: ot Yet Recruiting
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

A subject will be eligible for inclusion in this study only if all of the following criteria applied:

1. Children (patients) of age between infantile ages to 12 years of either sex.

2. Patients with pigmentary changes in the scalp region with associated with scalp infection.

3. Patients with secondary bacterial infection and candidiasis with localized scalp involvement and devoid of systemic manifestation.

Exclusion Criteria

A subject will be excluded from the study if any of the following criteria is applied:

1. Patients above12 years of age.

2. Patients associated with other generalized skin disorders of varied etiology and other manifestations.

3. Skin disorders with hereditary and metabolic etiology as well as chronic disorders and secondary lesions.

4. Patients who are on long term drug therapies.

5. Patients with Seborrheic Dermatitis extending to face shoulder and back region .

6. Extensive involvements of deeper skin tissue with tendency towards Psoriasis.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Primary outcomes: <br/ ><br>Improvement in symptoms of Arumshika (Seborrheic dermatitis) index. <br/ ><br>Timepoint: 8 WEEKS

Secondary Outcome Measures

Name	Time	Method
Reduced incidences of recurrent scalp infection and improvement in hair growth, texture, color with development of healthy scalp skin.Timepoint: 60 Days